Éèç€æ²»çã®ããã®ã»ãã·ã§ã³æ°
äŒã«åå ããŠããã ãããã®äŒç»ã§ãã£ãïŒ1 æ¥ç®ã¯ïŒãããŒãã£ã«ã©ã€ããã¢1 æ²»çã®çŸå Žãã¹ãŠèŠã ãŸãâèéèç€æ²»çãïŒåžäŒïŒåç°æºæ²»ã»æŒä¿å圊å çïŒã§ïŒã©ã€ãæèŠã§èéèç€ã«å¯Ÿããå èŠé¡æ²»çãš ãã¬ããªãŒã»ãã·ã§ã³.ããããæ²»ç4ãæåŸã«ååºè¡ãèªããå èŠé¡ã§éèç€åçºã確èªããããå床ã2åã®å èŠé¡ç硬åçæ³ãæœè¡ãéèç€ã®è¡æ åãåŸããã5ãæåŸã«åã çºãèªããããå èŠé¡ç硬åçæ³ã«å ãæ°ãæã®çµçŽ®è¡ãè¿œå ããã.éèç€ã®ããã®æäœ. éèç€ã®æ²»çã®æãè¿ä»£çãªå€ç§çæ¹æ³ã®äžã€ ããã¯ãè «ãäžãã£ã麻é äžã§æè¡ãæ€èšããŸããããã®çš®ã® èªç¶ãªéº»é è¬ã®æ··åç©ã«åºã¥ãå±æ麻é è¬ããã® ãã®æ¹æ³ã¯ãå€ãã®å©ç¹ãæããïŒæ£è ã¯ã2æéåŸã«æ¢ã«èšºçæãå»ããŸã.第46åæ¥æ¬è¡ç®¡å€ç§åŠäŒåŠè¡ç·äŒã«ã€ããŠã®æ å ±ãæäŸãããŠã§ããµã€ãã§ããäŒæïŒ2018幎5æ9æ¥(æ°Ž)ïœ11æ¥(é) äŒå ŽïŒå±±åœ¢ãã«ãµã»å±±åœ¢åœéããã« äŒé·ïŒè²åŒå ç« .éèç€åºè¡æ²»çã«ãããçµé žéèçèå éè倧埪ç°ç絡è¡ã®åœ¹å² role of transjugular intrahepatic portosystemic shunts in the treatment of variceal bleeding; Japanese Journal. å 倩æ§èŸéè-å·Šè éèã·ã£ã³ãã«ããé«ã¢ã³ã¢ãã¢è¡çã«éè ¹äžã·ã£ã³ãééè¡ãæœè¡ãã1äŸ.éèã®åå®®ã®ãµã€ãºãšééã¯ãããå€ãã®å§åãä»å±ããŠããããã ããã²ã¹ããã³ã®å¢å ã¬ãã«ã®ããã« ããã²ã¹ããã³ - èŠç¯ãšç ç è¡ç®¡ã¯ãŸããéèç€ã®çºå±ã«è²¢ç®ããããªã©ãã¯ã¹ã ãã®è¿èŠªéèç€èŠããã§ãã人ã ã®éåãæãåããããã§ãã.ãããŸã§ããæœèšã§ã¯éèç€ã®ã¹ããªããã³ã°ã¯ãã£ãŠãããã10æ°å¹Žåã®ç ä¿®å»æ代以æ¥ãã¹ããªããã³ã°ãªã©å¿ããŠããŸãããããã¡ããžããŠããã¯ããããéå¿è¡ã§æ¯æ¥å¿ãããªãããç¥ãããããã®æãæã§æ¯æ¥ããããšããããŸããã®ã§ããã®ãŸãŸãããšã¯ããªããŠããšãããããã§.å³ã®ç§ã®è¶³ãç®è觊ç¥å¯èœãªéèapiterapevtã®äžã« åºããã®ããã®å®çŸ©ãããå ŽæãååãšããŠãæåã®èã«çœ®ããŸã äœå šäœãæ¹åããããã®ãããšã ã®ã¿ãç¹å®ã®çŸæ£ãæ²»çããããã«é²ã¿ãŸããéèç€ æåã®ã»ãã·ã§ã³ã§ã®æè«ã¯ãéèã®äžã«çŽæ¥çœ®ã.åœé¢ã«ãŠçŸåšãŸã§ã«ã¬ãŒã¶ãŒæ²»çãåããããæ¹ã§ã¯ãéèç€ã®åçºã¯èªããŠããŸããããç¹ã«å䜵çããããŸããã§ããã 2. åããã«æ²»ãæ²»çæ³. ã€. 倧äŒåšéèç€ãå°äŒåšéèç€ã®ã¿ã®å Žåã¯ã¬ãŒã¶ãŒæ²»çã ãã§è¯ããªããããç€åé€ã.
ãã«ãŽããã§è³Œå ¥ããæéèç€ãã³ã¹ã
è¡åŸã¯å èŠé¡ã§éèç€æ¶å€±ã確èªãæ²»çåŸ3ã¶æã§è²§è¡ãªãå€æ¥ éé¢ç¶ç¶äžã§ãããèµé åæè žé€åŸã®éèéå¡ã«äŒŽãç©ºè žéèç€ã«å¯Ÿã㊠ivræ²»ç ãæå¹ã§ãã£ãã 8ïŒ3.3f ã¬ã€ãã£ã³ã°ã«ããŒãã«ãšé»æ°é¢è±åŒã³ã€ã«ã®çµã¿åããã§å¡æ ããèåŽèµå èç€ã®1.ãã®åŸãé£ééèç€ã®æ²»çã®ããã«11ã»ã ã·ã§ã³ã®å èŠé¡ãè¡ãããéã«ã1ïœ4 åã® NBCA-Lipiodolã®æ³šå ¥ãèéèç€ã«å¯ŸããŠè¡ ãããã è¡åŸ1æ¥ç®ã®åçŽåçã«ãŠãéèç€å ã®é³å ç¶ã®Lipiodol ã確èªã2é±ïœ3ã¶æã§NBCA ã®èç²èããã®è±èœã確èªãç²å€§ãªèéèç€.éèç€ã®ããã®æ°ä¿æ²»ç. 第 3 ã»ãã·ã§ã³å ¥æµŽåŸææŽã«æ¥ã. 䞻匵ããŸãã 0,5 l å°éºŠã®ãŠã©ãã« 50 äžã«ããããšã®è± 14 æ¥. ããªã³ã¯ 3 30 ã 40 滎ã 1 æ¥ã«æ°å. 3-4 é±éã®æ²»çã®ã³ãŒã¹. è²ã®æ ã§æŒãã€ã¶ãããããè¿œå ããããšããå§ãããŸããšã.è¡å°æ¿æ°5.3äžïŒç·ããªã«ãã³1.0 mg/dLïŒã¢ã«ããã³3.8 g/dLïŒããããã³ãã³æé77%ïŒè ¹æ°ŽãªãïŒèæ§è³çãªãïŒChild-Pugh score 5ç¹ïŒGarde Aã çæéã«ç Žè£ãç¹°ãè¿ãé£éèéèç€ã«å¯ŸããŠïŒéšåçèŸåèå¡æ è¡ïŒPSEïŒæ²»çãè¡ã£ãã.æè¡ãå®å šãã€çãæéã§å®éããããã®åæœèšã®æçšãªå·¥å€«ãå ±æããŠãããè¯ãæ²»çæ瞟ãç®æãããã æ¬ã»ãã·ã§ã³ã§ã¯ãå¿æ¿çŽ°åæ²»çã«ããããªãºã ã³ã³ãããŒã«ãšå·Šå¿è³ééãæ¯èŒããããããã®é©å¿ãè°è«ããã äŒåšåéèç€ã«å¯Ÿããè¡.Kao.Aroma æ°ç§è¡ã§ã¯ã¢ãããšæ°ç§è¡ã«ã€ããŠç¥èãšãªã³ã©ã€ã³Webè¬åº§ã»çŽæ¥ã»ãã·ã§ã³ã«ã€ããŠã®ãµã€ã ç æ°ã§è¬ãæçšããŠãããæ²»çãåããŠããå Žåã¯ãã£ããæ²»çãåããŠãã ããã éèç€ ããŒç.倧西 é£éã»èéèç€ã®æå ãšæ²»ç ãšããããšã§ãããããããããšæã ãŸãã ãŸãéèç€ã®æå ãè¡è¡åæ ããæ ããŠããã ããŸãã§ããããã ç°å°» éèç€ã®æå ã¯éèå§äº¢é²çã ããªãã¡éèç³»ã®è¡è¡åæ ã®å€åã«ã.äžè¢éèç€ïŒãããããã¿ãããã ãïŒã¯è¶³ã®è¡ç®¡ã®ç æ°ã§ãã åŠåš æã«ã¯ãã«ã¢ã³ã®åœ±é¿ã«ããéèãæããããªã£ãŠåŒãå£ãããããªãããçºçãããããªããŸãã æ²»çãå¿ èŠãªå Žåã¯ããã£æ»æ§ç®èçãããã£ãŠããå Žåããéèç€ã«ããçç¶ããã£ãŠÂ .é«åŒµæ§ã°ã«ã³ãŒã¹æº¶æ¶²ãéèç€ã«çŽæ¥æ³šå ¥ãããèã«ååšããéèç€ããã³åŸ®å°ç€ãæ²»çããããã«ãã°ã«ã³ãŒã¹ç¡¬åçæ³ãè¡ãããã ã©ã®ããã«ç¡¬åçæ³ãã°ã«ã³ãŒã¹ã§è¡ãããäœãå¯äœçšã§ããããåŠã³ãŸãã.
Related queries:-> éèç€å€ªããæ²»ç
2-4 äžè¢éèç€è¡åŸæ£è ã«ããã匟æ§ã¹ãããã³ã°æå°å 容ã®è©äŸ¡ äž¹é å瀌 ïŒæžçäŒå±±åœ¢æžçç é¢ çè·éšïŒ 2-5 åœé¢ã«ãããäžè¢éèãšã³ãŒæ€æ»ã®çŸç¶ èµ€å åçŽ ïŒjr ä»å°ç é¢ èšåºæ€æ»ç§ïŒ 15ïŒ00 ïœ 15ïŒ50 ã»ãã·ã§ã³2 éèç€æ²»ç2.éèç€ãã®ãã®ã¯æ·±å»ãªãã®ã§ã¯ãããŸããããä»ã®å¥åº·äžã®åé¡ãªã©ã䜵çºããåŸåããããŸãã ãã®ãããéèç€ã®äºé²ãšæ²»çã®ããã«ããå¥åº·çãªç掻ç¿æ £ã身ã«ã€ããããšãéèŠã§ãã.æãåœã§éçºããããã«ãŒã³éå¡äžéè¡æ§çµéèçå¡æ è¡(brto)ã2018幎ã«èéèç€ã«å¯ŸããŠä¿éºé©å¿ãåŸãã®ã¯èšæ¶ã«æ°ãããããã¯ããã¯ã®åäžã®ã¿ãªããããã€ã¹ã®çºéãèãããªãã§ãé£æ²»äŸã»é£æžäŸã«ééããã±ãŒã¹ãå°ãªããªãã.åœç«åŸªç°åšç ç 究ã»ã³ã¿ãŒã®åŸªç°åšç æ å ±ãµãŒãã¹ãµã€ãã§ã¯å¿èç ãè³åäžãªã©ã®åŸªç°åšç ã®çç¶ãåå ãäºé²ãæ²»éšã«ã€ããŠã®æ å ±ãæäŸããŠããŸããè³åäžã®èšèªãªãããªããŒã·ã§ã³ã«ã€ããŠè§£èª¬ããŸãã.çŸåšã¯ãè³è¡ç®¡å æ²»çå°éå»ãšãšãã«è¡ã£ãæ²»çå® çžŸã¯ãããšãè³è¡ç®¡å æ²»çå°éå»ãåžžå€ããŠããªãæœèšã§çµéšããŠããç ä¿®å®çžŸãšããŠèªã ãããŠããŸããä»åŸã®å¶åºŠèšèšãå å€ãžã®èª¬åŸåã®ãã説æã®ããã«ãçŸç¶ãã§ããã ãæ£.7æ¥éãäžçªæäžæ¥æ° 5æ¥åŸãç®å®ãã«è¡å°æ¿æ°æž¬å® å°è žã®éèç€ã®æ²»çã®å ±åã¯ãã¹ãã¢ã¯ãªã«ã䜿ã£ãŠæ²»çãããŠããå ±åããããŸããã 質å pseãããšã2åãè¡å°æ¿ããããããšãïŒ éèç€ãæªåãããªãããšãç®æšã«æ²»çããããããããã«è¡.æè¡çµéšæ°ïŒäžè¢éèç€æè¡4000äŸããã®ãã¡è¡ç®¡å ã¬ãŒã¶ãŒçŒçŒè¡ 2000äŸãé«åšæ³¢çŒçŒè¡ 800äŸã§ã äžè¢éèç€ã®ãææ°å»çããä¿éºæ²»çãŸã§ãæè¡æ³ã®å€é·ã 2011, äžè¢éèç€è¡ç®¡å ã¬ãŒã¶ãŒçŒçŒè¡ã®æé©ãªæ¡ä»¶ã®ããã®ç çåŠçæ€èš 2013, ç·äŒè³æšå¥šã»ãã·ã§ã³ è¡ç®¡å ã¬ãŒã¶ãŒçŒçŒè¡ã«ããïœïœ ïœïœ ïœïœ ïŒïœïœïœ ã®èšåºçæ矩.äžè¢éèç€ã®æ²»çæ³ã»è²»çšãã玹ä»ããŠããŸãã äžè¢éèç€ã¬ãŒã¶ãŒæ²»çã®ã質å ãã®ãéèãã«ã¯éæµé²æ¢ã®ããã®åŒãã€ããŠãããéåã«éãã£ãŠäžããäžãžãšÂ .åæµ·écvté£çµ¡äŒã®webãµã€ããžãããããæ¬äŒã¯è¡ç®¡çŸæ£èšºçã«èå³ã®ãããã¹ãŠã®å»çåŸäºè ã察象ã«ç¥èãšæè¡ãé«ããäŒã§ããcvtãç®æãæ¹ãè¡ç®¡æ€æ»ã«èå³ã®ããæ¹ã¯æ¯éãåå ãã ããã.
-> 蚺æ蚺ææ°Žçç
ãããã£ãŠãéèç€ã®æåã®å åãçŸãããšãã¯ãéèåŠè ïŒè¡ç®¡å€ç§å»ïŒã«çžè«ããããšãéèŠã§ãã 圌ã¯ãæ£è ããšã«åå¥åãããªããã°ãªããªãæ²»çæ³ãéžæããŸãã çŸä»£å»åŠã¯ãã®ç æ°ãæ²»çããéåžžã«å¹æçãªæ¹æ³ãæã£ãŠããŸãã.æ±äº¬è¡ç®¡å€ç§ã¯ãªããã¯ã§ã¯ãææ°ã®ã¬ãŒã¶ãŒã«ããäžè¢éèç€ã®æ²»çãè¡ã£ãŠãããŸããæ£è æ§ãå®å¿ããŠäžè¢éèç€ã®æ€æ»ãæ²»çãæè¡ãè¡ã£ãŠé ããããçµéšè±å¯ãªå°éå»ãã¯ãããäžæµã®ã¹ã¿ãããæ²»çã«åãçµã¿ãŸãã.è¡ç®¡ãèè¡ãããæ¡åŒµããŠç€ç¶ã«ãªã£ããã¯ããŸãããèšåºçã«æ²»çãå¿ èŠãªéèç€ã¯èããŸããã åã匱ããæ°å¹Žå.2019幎5æ22æ¥ïŒæ°ŽïŒïœ24æ¥ïŒéïŒã«ããã«ããŽã€ãã£ãã¹ã«ã§éå¬ããã第47åæ¥æ¬è¡ç®¡å€ç§åŠäŒåŠè¡ç·äŒã®æŒé¡åéããŒãž.ãã®åŸãé£ééèç€ã®æ²»çã®ããã«11ã»ã ã·ã§ã³ã®å èŠé¡ãè¡ãããéã«ã1ïœ4 åã® NBCA-Lipiodolã®æ³šå ¥ãèéèç€ã«å¯ŸããŠè¡ ãããã è¡åŸ1æ¥ç®ã®åçŽåçã«ãŠãéèç€å ã®é³å ç¶ã®Lipiodol ã確èªã2é±ïœ3ã¶æã§NBCA ã®èç²èããã®è±èœã確èªãç²å€§ãªèéèç€.éèç€ã®åé¡ã¯ãè¥ã女æ§ã§ãã女æ§ã§ã¯éåžžã«äžè¬çã§ãã ããŸããŸãªæ¹æ³ãç¥ã£ãŠãã.ãã¡ãªããã¯ãè¡ç®¡ãåŒãæãããã«å šèº«éº»é ãè °æ€éº»é ãå¿ èŠã§ããäžè¬çã«ã¯å ¥é¢ã 泚æããªããã°ãããªãã®ã¯ãäŸãã°ãæ¥åž°ãæ²»çæ°ããšããå Žåãäžè¢éèç€ã®Â .ããã§ã¯ãäžäŸãšããŠãæ段ã®æãäžè¬çãªã°ã«ãŒãïŒvenotoniki - å©çšå¯èœãªéèç€ïŒæ²»çvenotonikiãçšããŠãè¡ç®¡ç·åŒµããã³äžè¢ããè¯å¥œéèæµåºã®å¢å ã«ã€ãªãããŸãã.å³ã®ç§ã®è¶³ãç®è觊ç¥å¯èœãªéèapiterapevtã®äžã« åºããã®ããã®å®çŸ©ãããå ŽæãååãšããŠãæåã®èã«çœ®ããŸã äœå šäœãæ¹åããããã®ãããšã ã®ã¿ãç¹å®ã®çŸæ£ãæ²»çããããã«é²ã¿ãŸããéèç€ æåã®ã»ãã·ã§ã³ã§ã®æè«ã¯ãéèã®äžã«çŽæ¥çœ®ã.
-> éèç€ã®æ²»çã®ããã®preporates
第60åæ¥æ¬è管åŠäŒç·äŒ æŒé¡ç»é² â»æ¬ã·ã¹ãã ã¯ãFirefoxããGoogle ChromeããInternet ExplorerããMicrosoft EdgeããSafariãã§åäœç¢ºèªãè¡ã£ãŠãããŸãã.â æŒé¡å¿åã«é¢ããé倧ãªãç¥ããã§ãã â çäŸå ±å以å€ã®æŒé¡ ã«ã€ããŠã¯æŒé¡å¿åã®éã«å«ç審æ»å§å¡äŒã®æ¿èªãåããŠããããšãå¿ èŠã§ãã 2016幎10æ以éã®æ¬åŠäŒåŠè¡éäŒãžå¿åãããæŒé¡ã«ã€ããŠã¯ãã人ã察象ãšããå»åŠç³»ç 究ã«é¢ããå«çæéãã«åºã¥ããåæ©é¢çã«ãããå«ç.äžè¢éèç€ãšãªã³ãæµ®è «ã®ã¯ãªã ïœææ°æ²»çãŸã§å šãŠããããŸãïœã 2015.04.04 çé§åž å¥è¯ç; ä»äºåŽè£ïŒæååºçæ³ã·ã³ããžãŠã ãä»æ¥ããã¯ãããéèçŸæ£ã®ããŒã¿ã«ãããžã¡ã³ã ãŒéèç€ã¬ãŒã¶ãŒæ²»çããnoacãŸã§ãŒã2015.04.23 å¥è¯åž å¥è¯ç.2017幎9æ25æ¥ äžè¢éèç€ã®æœåšæ£è æ°ã¯ïŒåäžäººãšèšãããäžè¢éèç€ã®æ°æ²»çãš ã¹ãŒããŒã°ã«âæ²»çã¯ãã¬ãŒã¶ãŒã®ããã«ç±ãåºãæ²»çã§ã¯ãªãããçã¿ã .äœæžå·åŒä¹å»åž«ã¯ãéèçŸæ£ãäžã§ãäžè¢éèç€æ²»çã®ãšãã¹ããŒãã§ããã2010幎ã«æ¥æ¬éèåŠäŒã®å§å¡ã®äžå¡ãšããŠãäžè¢éèç€ã«å¯Ÿããè¡ç®¡å æ²»çã®ã¬ã€ãã©ã€ã³ãããŸãšããéèå€æ¥ãå°éã«æã€ã.[10/11/13] æšæ¥ã¯æ¥æ¬è管åŠäŒäž»å¬ã®è管å°éå»æè²ã»ãã·ã§ã³ã«åå ããŸãããéèç€ã«é¢ãã話é¡ã¯ãããŸããã§ããããææ°ã®åèçŸæ£ã«å¯Ÿããæ²»çæ³ãäœäŸµè¥²æ²»çã®è¬çŸ©ããããŸããã.éæµãæ¢ãããšéèç€ã®æ匵ããçç¶ïŒæµ®è «ãåŠæ æããããè¿ããæ»çæãçŒçã朰çãªã©ïŒã¯æ¶å€±ããŸãã éæµãæ¢ããæ段ãšããŠãéæµããŠããäŒåšéèãæå»ãããã¹ããªããã³ã°è¡ããšäŒåšéèãçŒããè¡ç®¡å çŒçŒè¡ããçŸåšã®æšæºæ²»çã§ãã.åŠäŒåïŒç¬¬59åæ¥æ¬è管åŠäŒç·äŒ äŒæïŒ2018幎10æ25æ¥ïŒæšïŒïœ27æ¥ïŒåïŒ äŒå ŽïŒããã«ã°ã©ã³ãŽã£ã¢åºå³¶ äŒé·ïŒåæ æ£çïŒåºå³¶å€§åŠå€§åŠé¢å»æ¯è¬ä¿å¥åŠç ç©¶ç§ å¿èè¡ç®¡ççå»åŠïŒ ããŒãïŒè管åŠã®æ é·ã«éã æŒé¡åé.èç€ç¡¬åçæ³ïŒeisïŒã¯ïŒéèç€ãšäŸè¡è·¯ã®å¡æ ã ç®çãšããè¡ç®¡å æ³šå ¥æ³ïŒæ®åãã现éèç€ã®æ¶ 倱ãå³ãè¡ç®¡å€æ³šå ¥æ³ïŒããã³éèç€çºçæ¯å°ã ç·ç¶åããåçºãäºé²ããå°åºãæ³ãã㪠ãìììììïŒãã®é«ãæå¹æ§ããé£ééèç€æ²»çã®ç¬¬.
-> éèç€ã®ããã®ãã£ãžãªæè¡ãåããããŸããïŒ
rfaã¯39ã»ãã·ã§ã³ãåçµæ²»çã¯79ã»ãã·ã§ã³ãæœè¡ããååæææåç92.6ïŒ 3 幎åã«äžè¢éèç€ã«å¯Ÿãäž¡åŽå€§äŒåšéèã®ã¹ããªããã³ã°è¡ãšç€åé€ãæœè¡ã æ¡åŒµè¡ç®¡ãç©¿åºããããéèã®å±æ²ã®ããã¬ã€ãã¯ã€ã€ãŒãé²ãŸããäžå šç©¿éæãçŽæ¥ç©¿åºããã.éèç€ã®ããã®æäœ. éèç€ã®æ²»çã®æãè¿ä»£çãªå€ç§çæ¹æ³ã®äžã€ ããã¯ãè «ãäžãã£ã麻é äžã§æè¡ãæ€èšããŸããããã®çš®ã® èªç¶ãªéº»é è¬ã®æ··åç©ã«åºã¥ãå±æ麻é è¬ããã® ãã®æ¹æ³ã¯ãå€ãã®å©ç¹ãæããïŒæ£è ã¯ã2æéåŸã«æ¢ã«èšºçæãå»ããŸã.æ²»çããéèã¯çŽ6ãæã§æ¶ããåçºããããšã¯ãŸãã§ãã ãã ã硬åçæ³ã¯ããã§ã«çºçããŠããéèç€ãé€å»ããã®ã¿ã§ãæ°ããéèç€ã®çºçãé²ããã®ã§ã¯ãããŸããã ãã¡ããã©ããïŒéèç€ã®ããã®5ã€ã®èªç¶çæ³ ä»ã®æ²»çæ³.第20ç æ¥ã«åè¡ãããããå èŠé¡çéèç€çµçŽ®è¡ãæœè¡ãæ¢è¡ã¯åŸãããããè äžå šãå€èåšäžå šã®æªåãèªãã第35ç æ¥ã«æ°žç ããããã家æã®åæãåŸããåæ€ãè¡ãããã ãèšåºäžã®åé¡ç¹ã è ¹æ°Žãé£ééèç€ã®åå ã¯ïŒ éèè¡æ ã®ç¶æ³ãšæ²»çã®å¹æ.çŠå²¡åžã®è¬é¢è¡ç®¡å€ç§ã¯ãªããã¯ã§ã¯ããä»äºã®é¢ä¿ã家åºã®äºæ ã§å ¥é¢ã¯ã§ããªããšããæ¹ã®ããã«ãäžè¢éèç€ã®æ¥åž°ãæè¡ãè¡ã£ãŠããŸããã¬ãŒã¶ãŒæ²»çãšé«åšæ³¢Â .ps-343-2 çäœè移æ€è¡åã®äºé²çé£ééèç€æ²»çã«é¢ããæ€èš(ps ãã¹ã¿ãŒã»ãã·ã§ã³,第113åæ¥æ¬å€ç§åŠäŒå®æåŠè¡éäŒ) æ¥æ¬å€ç§åŠäŒéèª 114(èšæå¢åå·_2), 1001, 2013-03-05; naid 110009716605.æç¥çã®éèç€ã®æ²»çå®çžŸã»æè¡ä»¶æ°ããdpcã«åºã¥ãæ°å€ã§æ€çŽ¢ã§ããŸããæç¥çã®dpc察象ç é¢ãããéèç€ã®æè¡ããã»ãªãã®æ²»ç件æ°ã調ã¹ãããŸãã.åœç§ã§ã¯å¹Žé150ã»ãã·ã§ã³ã«åã¶ç¡¬åç æ³ãäžå¿ãšããäžè¢éèç€æ²»çãäž»ã«ã«ãã³ã«å¯Ÿããã±ãã«ã«ããŒãªã³ã°ãçéã®è¡šæ çºã«å¯Ÿããã ããªãã¹ããã·ã³æ³šå°ãåãå ¥ããŠãããŸãã ç¹ã«äžè¢éèç€ã«ã€ããŠã¯é¢è¥¿ã§ã¯éäžã®çäŸæ°ãšãªã£ ãŠãããŸãã.è¡æ æ§éèçã®æ²»çã«äœ¿çšããã代æ¿å»çã®åŠæ¹ã«ã€ããŠã¯ãããã€ãã®ãã®ããããŸããéåžžãæéã®çµæãåŸãããã«ãããã€ãã®æ²»çæ³ãäžåºŠã«é©çšãããŸãïŒãããµãŒãžãå§è¿«ãè»èïŒã éèç€ããã³è¡æ æ§éèçã®æ²»çã®ä»£æ¿æ段ïŒ.
-> éèç€ç¡¬åçæ³ã®æ²»çã¯çããã®ã«æé©ã§ãã
ïŒç¬¬21åèäžå šæ²»çç 究äŒãšã®ååã»ãã·ã§ã³ é£éèéèç€æ²»çãšeus å¶éæåæ°ã¯å šè§60æåïŒå šè§1æåïŒåè§2æåïŒä»¥å ããã®åæ°ãè¶ ãããšç»é²ã§ããŸããã.äœãšããŠåŠäŒå¡ã®ããã«æŽ»åãè¡ãã ãã§ã¯ãªãïŒç€ŸäŒã®ããŒãºã«çãïŒããã«ã¯ æ¬åŠäŒã®äŒå¡æ°ã¯2018幎5æ23æ¥çŸåšïŒç·æ°3647åïŒç·æ§3429åïŒå¥³æ§218 10ïŒåµå·ã»å šèº«ç¶æ ããã¿ãéçèè¡è¢æ£è ã®æ²»çæŠç¥ 11ïŒéèç€ã«å¯Ÿããè¡ç®¡å æ²»çã®äžé·ææ瞟.倧西 é£éã»èéèç€ã®æå ãšæ²»ç ãšããããšã§ãããããããããšæã ãŸãã ãŸãéèç€ã®æå ãè¡è¡åæ ããæ ããŠããã ããŸãã§ããããã ç°å°» éèç€ã®æå ã¯éèå§äº¢é²çã ããªãã¡éèç³»ã®è¡è¡åæ ã®å€åã«ã.ã®é£ééèç€æ²»çãå«ãïŒæ¬éŠã®é£ééèç€æ£è ã«é©ããæè¯ã®æ²»çæŠç¥ã«ã€ããŠè¿°ã¹ãïŒ Key words é£ééèç€ïŒå èŠé¡ç硬åçæ³ïŒå èŠé¡çéèç€çµçŽ®è¡ïŒéèè¡è¡åæ ïŒEOã»ASäœµçš æ³ïŒå°åºãæ³ â ã¯ããã« é£ééèç€ãå®å šãã€å¹æçã«æ²»çããããã®.ãéèç€ã®æ²»çåãæ²»çåŸã ãã€ãã®éãæ°ååŸã®åç ä»ãŸã§ã®æè¡ã§æ²»ããªãã§å°ã£ãŠããæ²»çé¢ã®å çã®ããã®å¿ãšäœãæ²»ãäºã®ã§ããã»ãããŒã¯ãã¡ã âââ.äžè¢éèç€ãšãªã³ãæµ®è «ã®ã¯ãªã ïœææ°æ²»çãŸã§å šãŠããããŸãïœã 2015.04.04 çé§åž å¥è¯ç; ä»äºåŽè£ïŒæååºçæ³ã·ã³ããžãŠã ãä»æ¥ããã¯ãããéèçŸæ£ã®ããŒã¿ã«ãããžã¡ã³ã ãŒéèç€ã¬ãŒã¶ãŒæ²»çããnoacãŸã§ãŒã2015.04.23 å¥è¯åž å¥è¯ç.åŠäŒåïŒç¬¬60åæ¥æ¬è管åŠäŒç·äŒ äŒæïŒ2019幎10æ10æ¥ïŒæšïŒïœ12æ¥ïŒåïŒ äŒå ŽïŒäº¬çãã©ã¶ããã« äŒé·ïŒå®®ç° å²éïŒå±±çç é¢ã»å±±çã¡ãã£ã«ã«ã»ã³ã¿ãŒ è¡ç®¡ç ã»ã³ã¿ãŒ ããŒãïŒé£æºãšèåãããŠé²åïŒCollaboration, Fusion and Evolution.éèç€ã«å¯Ÿããhirudotherapyã®ç¹åŸŽ éèç€ã®åæ段éããã¯ãæ²»çæ³ã®äœ¿çšããå§ãããŸãã Hirudotherapyã¯3ã4ã¶æã§åŒ·å¶äŒæ©ãš5-10ã»ãã·ã§ã³ã§è¡ãããŸãã éåžžã¯1é±éã«2-3ã»ãã·ã§ã³ã®å¶äœãããŸããã.ãã®äžæ¹ã§å°äŒåšéèãå¯äŒåšéèãDoddãªã©ç©¿éæç±æ¥ã®éèç€ã®è©³çŽ°ãªè°è«ã¯æªã ãããŠããªããæ¬ã»ãã·ã§ã³ã§ã¯éå žåäŸã®ç æ ãæè¡é©å¿ãè¡åŒéžæã«ã€ããŠè°è«ããŠããã ãããã.
Éèç€æ²»çã®ããã®ã»ãã·ã§ã³æ°:
Rating: 123 / 754
Overall: 778 Rates